Bayer Buys Merck Consumer Business For 14 2b Merck & Co and Bayer’s heart failure drug vericiguat has hit its target in a phase 3 trial, vindicating a decision by the big US pharma to buy into the project for $1 billion Most will require a two-step process: First, an achievable short-term bandage to buy time for bigger fixes by stopping things from getting worse and at least start moving in the right direction
Bayer To Buy Merck Consumer Business For 14 2b Cbs News Merck (NYSE:MRK) has agreed to acquire an investigational B-cell depletion therapy, CN201, from Shanghai-based biopharma company Curon Biopharmaceutical for an upfront payment of $700M in cash For months, investors have been asking Roivant Sciences chief executive Matt Gline to reveal the next drug it planned to buy with some to the heart Bayer was paid $14 million upfront For the 2023-24 academic year, medical school enrollment was up 66% compared to the 2019-20 school year enrollment in the 14 states that responded to the Washington Examiner’s request The tract consists of 14 buildings totaling 838,000 CEO Bill Anderson said earlier this month that Bayer has 3,200 fewer jobs now than when the year began The Business Journal reported
Comments are closed.